Sanchita Sharma- Read all stories from Sanchita Sharma | Hindustan Times
close_game
close_game
Sanchita Sharma

Sanchita is the health & science editor of the Hindustan Times. She has been reporting and writing on public health policy, health and nutrition for close to two decades. She is an International Reporting Project fellow from Paul H. Nitze School of Advanced International Studies at the Bloomberg School of Public Health and was part of the expert group that drafted the Press Council of India’s media guidelines on health reporting, including reporting on people living with HIV.

Articles by Sanchita Sharma

A decade after defeating polio, India is set to begin its battle against Covid

With two approved vaccines – Serum Institute of India’s Covishield, and Bharat Biotech’s Covaxin -- India is kickstarting the world’s biggest Covid-19 vaccination drive with an aim to inoculate 300 million people at most risk of infection and death by August.

Home health care workers and their patients start receiving Moderna COVID-19 vaccines at a drive-thru vaccination clinic in Portland, Ore., Sunday, Jan. 10, 2021. The clinic is a partnership between the Service Employees International Union and Oregon Health & Science University, aiming to vaccinate Oregon's 32,000 home health care workers and their patients. (Kristyna Wentz-Graff/Pool Photo via AP)(AP)
Updated on Jan 11, 2021 11:54 AM IST

Scientists reset biological clock to restore vision in old mice

If affirmed through further studies, these findings could be transformative for the care of age-related vision diseases like glaucoma and to the fields of biology and medical therapeutics for disease at large

Representational Image.(File photo)
Updated on Dec 03, 2020 04:36 PM IST
Hindustan Times, New Delhi | By

India to manufacture 100mn doses a year of Sputnik: Moscow institute

Phase 3 clinical trials of the vaccine are approved and ongoing in Belarus, the UAE, Venezuela and other countries, and Phase 2/3 have been approved in India. India, along with Brazil, China, South Korea and others, will provide the vaccine to at least 50 countries that have requested over 1.2 billion doses.

Sputnik V is a human adenovirus-based vaccine candidate and the only late-stage adenovirus-based Covid-19 vaccine candidate to use two different vectors for different injections, human adenovirus types Ad5 and Ad26.(Bloomberg)
Published on Nov 28, 2020 07:24 AM IST
Hindustan Times, New Delhi | By, New Delhi

Over half of 20-year-olds in urban India likely to develop diabetes in their lifetime: Study

Those who were free of diabetes at age 60 were at lower risk, with around 38% of women and 28% of men developing diabetes at a later age, found the study that used data from Delhi and Chennai

Representational photo.(Getty Images/iStockphoto)
Updated on Nov 24, 2020 04:30 PM IST
Hindustan Times, New Delhi | By

Vaccinationalism will prolong pandemic: Andrea D. Taylor of Global Health Innovation Center

Some countries will be able to vaccinate their entire populations — and some many times over— while denying low-resource regions such as sub-Saharan Africa access to Covid-19 protection until 2024

Andrea D. Taylor, the assistant director of programs at Global Health Innovation Center, Duke University.(Sourced)
Updated on Nov 02, 2020 08:23 AM IST
Hindustan Times, New Delhi | By

Melinda Gates: ‘Life will change forever… we will build back in a better way’

The co-chair of Bill and Melinda Gates Foundation spoke about innovation, livelihoods, and how coronavirus disease will change the world

Melinda Gates, co-chair of the Bill and Melinda Gates Foundation.(AFP/Getty Images)
Updated on Oct 21, 2020 05:07 PM IST
Hindustan Times, New Delhi | By

Covid detection with CRISPR, phones in offing

This new CRISPR diagnostic method doesn’t amplify coronavirus RNA but uses multiple guide RNAs that work in tandem to increase the sensitivity of the test, said the research team in the yet to be peer-reviewed study published in the pre-print server medRxiv.

American biochemist Jennifer Doudna of the University of California at Berkeley, who won the 2020 Nobel Prize for Chemistry, poses with a CRISPR-Cas9 model taken in Berkeley, California.(via REUTERS)
Updated on Oct 11, 2020 05:35 AM IST
Hindustan Times | By

Genetic defects may affect ability to fight Covid-19

Lab studies confirmed the antibodies destroyed the interferon and cells exposed to the patients’ plasma failed to stop infection by Sars-CoV2, the virus that causes Covid-19.

A health worker in PPE coveralls prepares to collect swab samples for coronavirus testing at Rajendra Nagar in New Delhi on Wednesday.(Sanchit Khanna/HT Photo)
Updated on Sep 26, 2020 01:32 AM IST
Hindustan Times, New Delhi | By
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, September 12, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On